Anderson J L
Department of Medicine, University of Utah, Salt Lake City, USA.
Control Clin Trials. 1996 Jun;17(3 Suppl):17S-27S. doi: 10.1016/s0197-2456(96)00015-3.
This paper reviews trials of postmyocardial infarction therapies including beta adrenergic blockers, antiarrhythmic agents other than amiodarone, and thrombolytic drugs. The results of certain beta blockers on overall cardiovascular mortality and sudden death mortality after myocardial infarction are discussed, along with the results of CAST and subgroup analyses on patients at high risk for death. The effects of thrombolysis during acute myocardial infarction on subsequent arrhythmic mortality are also reviewed.
本文综述了心肌梗死后治疗的试验，包括β肾上腺素能阻滞剂、除胺碘酮以外的抗心律失常药物和溶栓药物。讨论了某些β受体阻滞剂对心肌梗死后总体心血管死亡率和猝死死亡率的影响，以及CAST的结果和对高危死亡患者的亚组分析结果。还综述了急性心肌梗死期间溶栓对随后心律失常死亡率的影响。
